STOCK TITAN

Outset Medical (OM) insider files to sell shares and settle RSUs

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Outset Medical (OM) has a notice of proposed sale of common stock by reporting person John Brottem. The filing lists 2,562 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on August 17, 2026, with an aggregate market value of $11,549.17. It also notes the settlement of 5,033 vested restricted stock units as equity compensation for services rendered, with the same August 17, 2026 date. In the prior three months, the reporting person sold 2,638 shares of common stock on May 15, 2026 for $9,760.60.

Positive

  • None.

Negative

  • None.
Shares to be sold 2,562 shares Common stock proposed sale through Morgan Stanley Smith Barney LLC
Aggregate market value $11,549.17 Value of 2,562 shares of common stock proposed for sale
Vested RSUs settled 5,033 shares Settlement of vested restricted stock units as equity compensation
Prior 3-month sale amount 2,638 shares Common stock sold on May 15, 2026 during past three months
Proceeds from prior sale $9,760.60 Total for 2,638 shares sold on May 15, 2026
Planned sale date August 17, 2026 Date for proposed sale and RSU settlement
Form 144 regulatory
"144: Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Units financial
"Settlement of Vested Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Equity Compensation financial
"08/17/2026 | Equity Compensation for services rendered"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"

FAQ

What stock sale is disclosed in Outset Medical (OM)'s Form 144?

The filing discloses a proposed sale of 2,562 shares of Outset Medical common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $11,549.17, planned for August 17, 2026.

Who is the reporting person in the Outset Medical (OM) Form 144 filing?

The reporting person is John Brottem, associated with sales and equity awards of Outset Medical common stock, including past sales and settlement of vested restricted stock units listed in the notice.

What equity compensation is reported for Outset Medical (OM) in this filing?

The document reports a settlement of 5,033 vested restricted stock units of Outset Medical common stock as equity compensation for services rendered, with a transaction date of August 17, 2026.

What prior stock sales by the reporting person are disclosed for OM?

The filing lists a prior sale of 2,638 shares of Outset Medical common stock on May 15, 2026, with total proceeds of $9,760.60 during the preceding three months.

On which market is the Outset Medical (OM) stock involved in this Form 144 listed?

The common stock referenced in the filing is listed on NASDAQ, as indicated in the securities information section alongside the proposed sale details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature